Moreover, IL-10 stimulates the expression of PD-L1 on tumor cells [59, 60], thereby inhibiting T cells and NK cells through the activation of the PD-1/PD-L1 immune checkpoint signaling pathway. The gene discussed is IL10; the disease is neoplasm.